Srinibas Pradhan Constructions IPO...
28 Feb, 2026
Medicamen Organics Limited IPO
Medicamen Organics Limited is engaged in developing, manufacturing and distributing a broad range of pharmaceutical dosages including generic dosages in the form of Tablets, Capsules, Oral Liquids, Ointments, Gel, Syrups, Suspension and Dry powders for government (including both state and central governments) and private institutions as contract manufacturer / third party manufacturer. They have a track record of operating a B2B model which covers the contract manufacturing model. Their manufacturing facilities are capable of producing pharmaceutical formulations and products and have a fully equipped quality control department with experienced and qualified staff to facilitate a smooth manufacturing process. Medicamen Organics IPO is a book-built issue of Rs 10.54 crores.
The issue is entirely a fresh issue of 31 lakh shares. Medicamen Organics IPO opens for subscription on June 21, 2024 and closes on June 25, 2024. The allotment for the Medicamen Organics IPO is expected to be finalized on Wednesday, June 26, 2024. Medicamen Organics IPO price band is set at ₹32 to ₹34 per share. The minimum lot size for an application is 4000 Shares. GYR Capital Advisors Private Limited is the book-running lead manager of the Medicamen Organics IPO, while Kfin Technologies Limited is the registrar for the issue. The market maker for Medicamen Organics IPO is Giriraj Stock Broking.
WHAT IS GMP?
GMP (Grey Market Premium) is the difference between the IPO price and the grey market price. It is the premium amount paid for the traded IPO shares. It plays an important role in IPOs as it reflects how the IPO would react on the listing day.
A grey market is a place where shares/stocks are traded before being listed officially on the stock exchange.
Medicamen Organics Limited IPO GMP
| GMP Date | IPO Price | GMP | Last Updated |
|---|---|---|---|
| - | - | - | - |
**The GMP prices displayed here are solely for informational purposes related to the grey market news. India IPO does not engage in or facilitate grey market trading, nor are these rates (sub2) indicative of any trading activity. We also do not recommend or endorse participation in the grey market.**
Medicamen Organics Limited IPO Details
| Detail | Description |
|---|---|
| IPO Date | June 21, 2024 to June 25, 2024 |
| Listing Date | - |
| Face Value | ₹10 per share |
| Price Band | ₹32 to ₹34 per share |
| Lot Size | 4000 Shares |
| Total Issue Size | 3,100,000 shares (aggregating up to ₹10.54 Cr) |
| Fresh Issue | 3,100,000 shares (aggregating up to ₹10.54 Cr) |
| Issue Type | Book Built Issue IPO |
| Listing At | NSE SME |
| Share holding pre issue | 8,600,000 |
| Share holding post issue | 11,700,000 |
| Market Maker portion | 172,000 shares |
Medicamen Organics Limited IPO Timeline
| Detail | Description |
|---|---|
| IPO Open Date | Friday, June 21, 2024 |
| IPO Close Date | Tuesday, June 25, 2024 |
| Basis of Allotment | Wednesday, June 26, 2024 |
| Initiation of Refunds | Thursday, June 27, 2024 |
| Credit of Shares to Demat | Thursday, June 27, 2024 |
| Listing Date | Friday, June 28, 2024 |
| Cut-off time for UPI mandate confirmation | 5 PM on June 25, 2024 |
Medicamen Organics Limited IPO Lot Size
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Retail (Min) | 1 | 4000 | ₹136,000 |
| Retail (Max) | 1 | 4000 | ₹136,000 |
| HNI (Min) | 2 | 8,000 | ₹272,000 |
Medicamen Organics Limited IPO Promoter Holding
| Share Holding Pre Issue | Share Holding Post Issue |
|---|---|
| Share Holding Pre Issue | 81.21% |
| Share Holding Post Issue | - |
Competitive Strength:
- -
Medicamen Organics Limited IPO Financial Information
| Period Ended | Assets | Total Income | Profit After Tax | Net Worth | Reserves and Surplus | Total Borrowing | ||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 31 Mar 2024 | 3,858.07 | 2,528.96 | 240.41 | 1,518.40 | - | 1,265.65 | ||||||||||||||||||||||||||||||||||
| 31 Mar 2023 | 3,211.98 | 2,296.24 | 95.78 | 1,518.40 | - | 1,179.50 | ||||||||||||||||||||||||||||||||||
| 31 Mar 2022 | 2,707.21 | 2,118.67 | 9.23 | 755.92 | - | 1,024.57 | ||||||||||||||||||||||||||||||||||
| 31 Mar 2021 | 2,634.37 | 2,505.96 | 29.81 | 746.72 | - | 958.97 | ||||||||||||||||||||||||||||||||||
| Amount in ₹ Crore | ||||||||||||||||||||||||||||||||||||||||
Key Performance Indicator
| KPI | Values |
|---|---|
| ROE | 19.90% |
| ROCE | 14.50% |
| Debt/Equity | 0.83RoNW |
| RoNW | 15.83 |
| P/BV | 2.39 |
| PAT Margin (%) | 9.51 |
| Pre IPO | Post IPO | |
|---|---|---|
| EPS (Rs) | ||
| P/E (x) |
Objectives of Medicamen Organics IPO
The company proposes to utilize the Net Proceeds from the Issue towards the following objectives:
- 1. Funding of expenses proposed to be incurred towards Product registration in the international markets;
- 2. Plant updation and increase in production capacity;
- 3. Funding working capital requirements of our Company; and
- 4. General Corporate Purposes.
Medicamen Organics IPO Review
The company is operating in a highly competitive and fragmented segment of Pharma products. It posted average financial performance for the reported periods with a boosted bottom line for FY24. Based on FY24 earnings, the issue appears fully priced. Well-informed investors may park moderate funds for long-term rewards.
RHP:
View RHPDRHP:
View DRHPRead more :
Frequently Asked Questions (FAQs)
-
What is Medicamen Organics IPO?
Medicamen Organics IPO is an NSE SME IPO. They are going to raise ₹10.54 Crores via IPO. The issue is priced at ₹32 to ₹34 per equity share. The IPO is to be listed on NSE.
-
When will Medicamen Organics IPO?
The IPO is to open on June 21, 2024, for QIB, NII, and Retail Investors.
-
What is Medicamen Organics IPO Investors Portion?
The investors’ portion for QIB is 50%, NII is 15%, and Retail is 35%.
-
What is Medicamen Organics IPO Size?
Medicamen Organics IPO size is ₹10.54 crores.
-
What is Medicamen Organics IPO Price Band?
Medicamen Organics IPO Price Band is ₹32 to ₹34 per equity share.
